Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New urine test could spot bladder cancer early in remote greenland

NCT ID NCT06281691

Diagnosis Sponsor: Jørgen Bjerggaard Jensen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a simple urine test (Xpert Bladder Cancer Detection Test) can accurately detect bladder cancer in people undergoing cystoscopy. Researchers enrolled 127 adults in Greenland, where access to urology services is limited. The goal was to see if the urine test could help decide who really needs a cystoscopy, potentially leading to earlier diagnosis and better outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Xpert® Bladder Cancer Detection Test (urine test)
What this could lead to
If successful, this urine test could help detect bladder cancer earlier in remote areas with limited access to specialists, potentially improving survival.
What could go wrong
This is a small, completed observational study (127 participants) testing accuracy, not a treatment. The urine test may not be reliable enough to replace cystoscopy in all cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

127 people

The number who actually took part.

Started

Dec 2023

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Individuals aged 18 and above who reside in Greenland and are currently on the waiting list to undergo cystoscopy.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ≥18 years of age at the time of signing the Informed Consent Form with an indication for cystoscopy and planned for this already at study inclusion. * Ability to understand the Participant Information Sheet orally and in writing in either Danish or Greenlandic. * Signed Informed Consent Form. * Is, according to the Investigator's judgement, able to comply with the trial protocol. Exclusion Criteria: * Patients not willing to participate.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Urinary bladder neoplasms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

urinary bladder neoplasm Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Urinary bladder neoplasms

Contacts and locations

Locations

  • Department of Urology, Aarhus University Hopsital

    Aarhus, 8000, Denmark

  • Queen Ingrid's Hospital

    Nuuk, 3900, Greenland

More trials for these conditions

Other studies related to the condition(s) this trial covers.